Align Technology(US:ALGN) ZACKS·2025-04-10 10:40Core Insights - Align Technology (ALGN) shares increased by 14.4% to close at $165.03, following a notable trading volume, contrasting with a 12.6% loss over the past four weeks [1][2] Financial Performance Expectations - The company is set to release its Q1 2025 financial results on April 30, with earnings expected to be $2 per share, reflecting a year-over-year decline of 6.5%. Revenue is projected at $978.1 million, down 1.9% from the previous year [2][3] - The last reported fourth quarter saw earnings surpass the Zacks Consensus Estimate by 0.4%, with expectations for the upcoming quarter to benefit from the commercialization of the Invisalign Palatal Expander system [2][3] Earnings Estimate Trends - The consensus EPS estimate for Align Technology has been revised slightly lower over the past 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [4] - The stock currently holds a Zacks Rank of 2 (Buy), suggesting a favorable outlook compared to other stocks in the same industry [4] Industry Context - Align Technology operates within the Zacks Medical - Dental Supplies industry, where Cardinal Health (CAH) also operates, finishing the last trading session up 4.4% at $130.45, with a 0.7% return over the past month [4][5] - Cardinal Health's consensus EPS estimate has changed by -0.1% to $2.15, representing a year-over-year increase of 3.4%, and it currently holds a Zacks Rank of 3 (Hold) [5]